Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
Classifica tra le azioni #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
Prezzo delle azioni
$0.00733708
Ultima sincronizzazione: 2026-04-23
Capitalizzazione di mercato
$273.87K
Variazione (1 giorno)
-39.13%
Variazione (1 anno)
-94.83%
Paese
NO
Scambia PCI Biotech Holding ASA (PCIB)

Categoria

Rapporto P/S per PCI Biotech Holding ASA (PCIB)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PCI Biotech Holding ASA, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per PCI Biotech Holding ASA da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE